Author details

Full Name

Deborah F Mason

Affiliation

ORCID

Career Start Year

2005

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36882223	Multiple sclerosis mortality in New Zealand: a nationwide prospective study.		2023
36149605	Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand.		2023
38085047	Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.		2023
34820847	Standardized mortality ratios in multiple sclerosis: Systematic review with meta-analysis.	Acta Neurologica Scandinavica	2022
35216788	Response to treatment in NMOSD: the Australasian experience.	Multiple Sclerosis and Related Disorders	2022
34387513	The effect of national disease-modifying therapy subsidy policy on long-term disability outcomes in people with multiple sclerosis.	Multiple Sclerosis Journal	2022
34374460	A Multi-Step Model of Parkinson's Disease Pathogenesis.	Movement Disorders	2021
33704407	The latitude gradient for multiple sclerosis prevalence is established in the early life course.	Brain	2021
33588597	Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.	Stroke	2021
33310879	Increased Large Vessel Occlusive Strokes After the Christchurch March 15, 2019, Terror Attack.	Neurology	2021
33426732	Functional neurological disorders presenting as emergencies to secondary care.	European Journal of Neurology	2021
34566866	MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis.	Front Neurol	2021
32612571	Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation.	Front Neurol	2020
32006158	The clinical profile of NMOSD in Australia and New Zealand.	J Neurol	2020
29760676	Helsinki Stroke Model Is Transferrable With "Real-World" Resources and Reduced Stroke Thrombolysis Delay to 34â¿¿min in Christchurch.	Frontiers in Neurology	2018
30177910	Functional Connectivity Alterations Reveal Complex Mechanisms Based on Clinical and Radiological Status in Mild Relapsing Remitting Multiple Sclerosis.	Frontiers in Neurology	2018
27891575	Multiple Sclerosis impact on employment and income in New Zealand.	Acta Neurologica Scandinavica	2017
28550069	Incidence and prevalence of NMOSD in Australia and New Zealand.	J Neurol Neurosurg Psychiatry	2017
26432856	An investigation of the relationship between latitude and multiple sclerosis severity in New Zealand.	Multiple Sclerosis Journal	2016
26765754	Disability profile of multiple sclerosis in New Zealand.	Journal of Clinical Neuroscience	2016
26602610	Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.	Psychiatry Research	2015
26224184	A new era in the treatment of multiple sclerosis.	Med J Aust	2015
24556851	The increasing prevalence of multiple sclerosis in New Zealand.	Neuroepidemiology	2014
24039024	Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis.	Journal of Neurology, Neurosurgery and Psychiatry	2014
24331795	Optic neuritis.	Lancet Neurology, The	2014
24503208	Multiple sclerosis in New Zealand.	Journal of Clinical Neuroscience	2014
24993136	Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of Neurologists.	J Clin Neurosci	2014
24993135	Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurologists.	J Clin Neurosci	2014
24986155	Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists.	J Clin Neurosci	2014
24852927	Multiple sclerosis in New Zealand MÄori.	Multiple Sclerosis Journal	2014
25145370	Cephalic tetanus complicating geriatric fall.	New Zealand Medical Journal	2014
23530001	Assessing possible selection bias in a national voluntary MS longitudinal study in Australia.	Multiple Sclerosis Journal	2013
24076602	Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.	Nat Genet	2013
22373014	Method for identifying eligible individuals for a prevalence survey in the absence of a disease register or population register.	Internal Medicine Journal	2012
22382255	A review of interferon use in patients with relapsing remitting multiple sclerosis in the Canterbury region, New Zealand: 2000-2006.	N Z Med J	2012
21833088	Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.	Nature	2011
22190364	Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.	Ann Neurol	2011
20605461	A review of tuberculous meningitis at Auckland City Hospital, New Zealand.	Journal of Clinical Neuroscience	2010
20813774	MS prevalence in New Zealand, an ethnically and latitudinally diverse country.	Multiple Sclerosis Journal	2010
20605462	Neurological and systemic complications of tuberculous meningitis and its treatment at Auckland City Hospital, New Zealand.	Journal of Clinical Neuroscience	2010
19200732	Acute inflammatory encephalomyelitis following Campylobacter enteritis associated with high titre antiganglioside GM1 IgG antibodies.	Journal of Clinical Neuroscience	2009
15774443	Detection of focal cerebral hemisphere lesions using the neurological examination.	Journal of Neurology, Neurosurgery and Psychiatry	2005